Numan Unees is the first MS patient in Sheffield to trial a new immunotherapy treatment.

Treatment with stem cells is safe and shows signs of slowing brain atrophy in people with progressive MS, per long-term early study data.

A registry study led by the University of Oulu examined the early-stage treatment of relapsing-remitting multiple sclerosis (MS) in Finland between 2013 and 2022. According to the study published in ...

HOUSTON & WALTHAM, Mass.--(BUSINESS WIRE)--Biostate AI, a leading innovator in artificial intelligence for RNA sequencing, today announced a strategic partnership with the Accelerated Cure Project ...

Add Yahoo as a preferred source to see more of our stories on Google. BUFFALO, N.Y. (WIVB) — More than a thousand people gathered at Terminal B at the Outer Harbor with one goal in mind Saturday ...

Multiple sclerosis (MS) is one of the most common autoimmune diseases affecting the brain and spinal cord, with 2.9 million people estimated to be living with the disease worldwide. As MS is an ...

MS is a chronic, immune-mediated disease affecting the central nervous system, with no known cure and varying levels of impact on individuals. Over 20 FDA-approved disease-modifying therapies exist, ...

PARIS — The first real guidelines on the use of disease-modifying therapies in multiple sclerosis (MS) have been released by a European joint venture between the European Committee for Research and ...

As recently as the ‘90s, when patients arrived with all the typical symptoms — memory loss, double vision, fatigue — neurologists often avoided confirming what they most suspected: that the patient ...

Should multiple sclerosis (MS) patients stop disease-modifying treatment (DMT) as they get older? The answer depends on several factors, noted John Corboy, MD, of the Rocky Mountain MS Center at the ...

BUFFALO, N.Y. (WIVB) — More than a thousand people gathered at Terminal B at the Outer Harbor with one goal in mind Saturday morning — making the step forward toward finding a cure for multiple ...